Comparative Genomics and Proteomics in Drug Discovery

Front Cover
John Parrington, Kevin Coward
Taylor & Francis Group, 2007 - Science - 182 pages

Comparative Genomics and Proteomics in Drug Discovery gives an overview of how emerging genomic and proteomic technologies are making significant contributions to global drug discovery programs, and in particular the key role that comparative genomics and proteomics play within this strategy. Each chapter is written by respected authorities, with hands-on experience, from both academic and pharmaceutical backgrounds.

From inside the book

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Comparative genomics of trypanosomatids
3
2
20
Nicotinic acetylcholine receptors as drugchemical targets
93
Copyright

21 other sections not shown

Other editions - View all

Common terms and phrases

About the author (2007)

John Parrington and Kevin Coward, Department of Pharmacology, University of Oxford, UK.

Bibliographic information